297387
HIA of Gender Pay Inequity
Acknowledging that the HIA methodology has become a more widespread tool for public health practice, the team used this framework to predict potential future health impacts of economic policies and legislation, to educate legislators and to increase community involvement in public health decision making. HIA activities included applying the five traditional steps of the HIA process: screening, scoping, assessment, recommendation and reporting results. The main focus of the research included a detailed literature review, as well as collection and analysis of primary and secondary local, state and national data.
Results clearly indicate that the adoption of pay equity legislation can improve women’s and children’s health statuses and outcomes. Implementing this methodology can also serve to build momentum for the use of the HIA framework to examine other proposed policies and to increase public health advocacy efforts pertaining to other women’s and children’s health issues such as infant mortality reduction.
Learning Areas:
Advocacy for health and health educationPublic health or related public policy
Systems thinking models (conceptual and theoretical models), applications related to public health
Learning Objectives:
Describe a scenario where the health impact assessment (HIA) methodology was used assess the health impacts of gender pay inequity. Discuss how HIAs can assist public health practitioners to inform decision makers and promote public advocacy by fostering diverse community engagement and broad public health stakeholder collaboration.
Keyword(s): Maternal and Child Health, Advocacy
Qualified on the content I am responsible for because: I am qualified to be an abstract author because I have received training on how to conduct health impact assessments, have led a team to conduct an HIA, am the primary author of an HIA, have provided consultation to others on how to successfully apply the HIA model and have an MPH.
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.